Anthony Caggiano Cognition Therapeutics Inc (CGTX) insider trading activity

Anthony Caggiano is Chief Medical Officer of COGNITION THERAPEUTICS INC. Currently has a direct ownership of 463,273 shares of CGTX, which is worth approximately $1.12 Million. The most recent transaction as insider was on Jul 29, 2025, when has been sold 20,281 shares (Common Stock) at a price of $0.67 per share, resulting in proceeds of $13,588. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 463K

10.68% 3M change

227.1% 12M change

Total Value Held $1.12 Million

Anthony Caggiano Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jul 29 2025	SELL Payment of exercise price or tax liability	$13,588 $0.67 p/Share	20,281 Reduced 4.19%	463,273 Common Stock
Jul 29 2025	BUY Grant, award, or other acquisition	-	65,000 Added 11.85%	483,554 Common Stock
Feb 15 2025	SELL Payment of exercise price or tax liability	$3,124 $0.59 p/Share	5,296 Reduced 1.25%	418,554 Common Stock
Feb 04 2025	BUY Grant, award, or other acquisition	-	295,000 Added 41.04%	423,850 Common Stock
Feb 03 2025	SELL Payment of exercise price or tax liability	$8,561 $0.67 p/Share	12,779 Reduced 9.02%	128,850 Common Stock
Feb 15 2024	BUY Grant, award, or other acquisition	-	60,000 Added 29.76%	141,629 Common Stock
Feb 03 2024	SELL Payment of exercise price or tax liability	$29,259 $2.29 p/Share	12,777 Reduced 13.53%	81,629 Common Stock
Feb 03 2023	BUY Grant, award, or other acquisition	-	94,406 Added 50.0%	94,406 Common Stock

Anthony Caggiano

Chief Medical Officer

Purchase,, NY

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CGTX shares.

Notify only if

Value

Insider Trading

Get notified when an Cognition Therapeutics Inc insider buys or sells CGTX shares.

Notify only if

Operation

Value

Type

News

Receive news related to COGNITION THERAPEUTICS INC

Track Activities on CGTX

Account